EverSource Wealth Advisors’s Pulse Biosciences PLSE Stock Holding History

EverSource Wealth Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61K	Sell	58 -291	-83%	-$6.87K	﹤0.01%	3805
2026 Q1	$7.54K	Buy	+349	New	+$6.44K	﹤0.01%	3069
2025 Q4	–	Sell	-24	Closed	-$425	–	4398
2025 Q3	$425	Sell	24 -5	-17%	-$79	﹤0.01%	3987
2025 Q2	$438	Buy	29 +16	+123%	+$265	﹤0.01%	3927
2025 Q1	$209	Buy	13 +11	+550%	+$205	﹤0.01%	3697
2024 Q4	$35	Buy	+2	New	+$35	﹤0.01%	3668

Other funds holding PLSE

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

EverSource Wealth Advisors's PLSE Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Pulse Biosciences (PLSE) stake by 83% in Q2 2026, selling an estimated $6.87K and leaving 58 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #3805.

EverSource Wealth Advisors first reported a position in PLSE in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.54K in Q1 2026. 20 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

EverSource Wealth Advisors held 58 shares of Pulse Biosciences worth $1.61K as of Q2 2026.
EverSource Wealth Advisors sold 291 Pulse Biosciences shares in Q2 2026, an estimated $6.87K.
Pulse Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3805 holding.
EverSource Wealth Advisors first reported a position in Pulse Biosciences in Q4 2024 and has held it in 6 quarters since.
EverSource Wealth Advisors's Pulse Biosciences position peaked at $7.54K in Q1 2026.
20 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.